Heart, kidney, and bone intertwined

Kidney Disease and Your Heart: How Parathyroidectomy Can Help

"Discover the link between kidney disease, bone health, and heart function, and how parathyroidectomy offers hope for patients with chronic kidney disease."


If you're navigating the complexities of chronic kidney disease (CKD), you're likely aware of the many challenges it presents. What might surprise you is the strong connection between your kidneys, your bones, and your heart. Cardiovascular disease is a leading cause of mortality for individuals with end-stage renal disease (ESRD), making it crucial to understand all facets of this intricate relationship.

One key player in this connection is heart rate variability (HRV), a measure of the variation in time between heartbeats. Reduced HRV often indicates an overactive sympathetic nervous system, increasing the risk of cardiovascular events and sudden death in CKD patients. Fortunately, there's a procedure called parathyroidectomy (PTX) that's showing promise in improving HRV and overall well-being for those with severe secondary hyperparathyroidism (SHPT), a common complication of CKD.

This article will explore the effects of parathyroidectomy (PTX) on blood bone markers and heart rate variability in patients with stage 5 chronic kidney disease, and shed light on how this procedure can help protect your heart and improve your quality of life.

AI Search Multiple angles on this topic

Why the Connection Matters

Kidney disease can affect more than kidney function and may also influence cardiovascular health. When kidney problems and mineral or hormone imbalances occur together, clinicians may consider how treatment could affect the heart as well as the kidneys. The relationship is complex, so individual risks and potential benefits should be assessed with a qualified healthcare professional.

Treatment Requires Individual Assessment

Management may involve monitoring kidney function, mineral levels, hormone levels, and cardiovascular risk over time. Parathyroidectomy can be considered in selected patients, but surgery is not appropriate for everyone and carries potential risks. Decisions generally depend on the underlying condition, disease severity, symptoms, and overall health.

An Evolving Understanding

Medical understanding of kidney disease has expanded from focusing primarily on filtration to recognizing broader effects on mineral balance, hormones, bones, and the cardiovascular system. This broader perspective has helped connect parathyroid disorders with complications beyond the neck. Treatment approaches continue to develop as clinicians refine how these conditions are evaluated and managed.

What's the Connection Between CKD, Bones, and Heart Health?

Heart, kidney, and bone intertwined

Chronic kidney disease-mineral and bone disorder (CKD-MBD) is a frequent complication as CKD progresses. It’s characterized by mineral and bone metabolism disruption, abnormalities in the bone, as well as vascular calcification – all of which lead to increased cardiovascular risks and higher mortality. Secondary hyperparathyroidism (SHPT) is a condition where the parathyroid glands become overactive, leading to excess parathyroid hormone (PTH) production. It exacerbates bone pain and fractures and increases CVD and mortality risks.

Parathyroidectomy (PTX) has emerged as an effective method for treating severe SHPT. Although bone biopsy is traditionally the standard for diagnosing bone mineral disorders, it is often impractical for patients because of its invasiveness. Therefore, researchers and clinicians often use non-invasive biomarkers to assess CKD-MBD.

  • Intact parathyroid hormone (iPTH): Regulates bone remodeling.
  • Bone-specific alkaline phosphatase (BAP): Indicates bone formation.
  • Tartrate-resistant acid phosphatase 5b (TRACP-5b): Indicates bone resorption.
  • Fibroblast growth factor 23 (FGF23): A hormone derived from bone.
AI Search Multiple angles on this topic

Evidence Continues to Develop

Research continues to examine how parathyroid hormone abnormalities and kidney disease interact with cardiovascular health. Studies may help clarify which patients are most likely to benefit from parathyroidectomy and how outcomes should be measured. However, available evidence may not answer every question, so treatment decisions still require individualized clinical judgment.

Surgery Is Not a Guaranteed Solution

Parathyroidectomy may address excessive parathyroid activity, but it cannot eliminate every cardiovascular risk associated with kidney disease. Surgery also has potential complications and may not produce the same results for every patient. These limitations make careful selection, informed consent, and follow-up important parts of treatment.

Chronic Disease Requires Long-Term Care

A chronic condition is generally persistent or long-lasting, and Wikipedia notes that the term is often used when a disease lasts more than three months. Kidney disease fits within this long-term framework, meaning treatment decisions must be considered alongside ongoing monitoring and management. The related entry for "Chronic" identifies chronic condition as one meaning of the term, while also noting that the word can refer to unrelated subjects such as chronic toxicity, the 2015 film Chronic, and Dr. Dre's 1992 album The Chronic. These definitions show why the medical context matters when comparing long-term conditions and their treatments.

These biomarkers provide valuable insights into the complex interplay between kidney disease, bone health, and heart function, guiding treatment strategies and improving patient outcomes.

Taking Steps for a Healthier Heart and Better Kidney Health

The findings of this research shows that parathyroidectomy can significantly improve heart rate variability and bone health in individuals with stage 5 chronic kidney disease. By understanding the connection between your kidneys, bones, and heart, you can take proactive steps to protect your overall health. Work closely with your healthcare team to monitor your bone markers, manage your PTH levels, and explore all available treatment options.

AI Search Multiple angles on this topic

Balancing Kidney and Heart Health

Parathyroidectomy may be an important option for some people with kidney disease and parathyroid-related complications. Its potential value should be considered alongside surgical risks, existing cardiovascular disease, and the person’s broader treatment plan. A balanced discussion with specialists can help clarify whether the expected benefits justify the risks.

Toward More Targeted Care

Future care may focus on identifying which patients are most likely to gain cardiovascular or overall health benefits from parathyroidectomy. Better long-term evidence could also improve timing, patient selection, and follow-up. Until then, clinicians must combine emerging research with each patient’s clinical circumstances.

Complex Care Pathways

People with kidney disease may need coordinated care across nephrology, endocrinology, surgery, and cardiology. Access to specialists, laboratory monitoring, and long-term follow-up can influence how effectively complications are recognized and treated. These practical factors are part of the broader challenge of managing interconnected chronic diseases.

Decisions Are Personal

A decision about parathyroidectomy affects more than laboratory results or cardiovascular risk estimates. Patients may weigh symptoms, surgical concerns, treatment burden, quality of life, and personal priorities differently. Shared decision-making can help ensure that the chosen approach reflects both the medical evidence and the individual’s goals.

What the mortality comparisons quantify

  • 28%; 37%A comparison with medical treatment reported a 28% relative reduction in all-cause mortality and a 37% relative reduction in cardiovascular mortality among PTx-treated patients.[1]

What the comparisons do and do not establish

Taken together, the treatment comparisons point in the same direction: surgery was linked with better survival outcomes than the respective nonsurgical comparators. Because the evidence is mostly observational and has moderate risk of bias, it cannot establish that surgery alone produced those differences.[2]

The source review also notes indirect comparisons and inconsistent reporting of adverse events. That leaves uncertainty not only about how confidently to attribute the mortality patterns to surgery, but also about how fully the available evidence captures possible harms.[2]

What remains unclear about outcomes and harms

  • How much of the observed survival difference is attributable to surgery rather than differences between patients receiving surgical and medical treatment? The evidence is largely observational and includes indirect comparisons.[2]
  • How do PTH fragments affect cardiovascular function, and how should their presence shape interpretation of circulating iPTH measurements? Their cardiovascular effects remain unclear.[3]

About this Article -

Written with AI assistance from published research, and reviewed by the Mystum team. See our About page for more information.

Everything You Need To Know

1

What is the relationship between Chronic Kidney Disease (CKD) and heart health?

There is a strong connection between Chronic Kidney Disease (CKD) and heart health. Cardiovascular disease is a leading cause of mortality for individuals with End-Stage Renal Disease (ESRD). Reduced Heart Rate Variability (HRV) often indicates an overactive sympathetic nervous system, which can increase the risk of cardiovascular events. CKD-Mineral and Bone Disorder (CKD-MBD) is a frequent complication of CKD, characterized by mineral and bone metabolism disruption, which leads to increased cardiovascular risks. This complex relationship highlights the importance of understanding how CKD impacts cardiovascular health and seeking appropriate treatment.

2

What role does Parathyroidectomy (PTX) play in managing the complications of Chronic Kidney Disease?

Parathyroidectomy (PTX) is a surgical procedure that has shown promise in improving heart rate variability (HRV) and overall well-being in patients with severe Secondary Hyperparathyroidism (SHPT), a common complication of Chronic Kidney Disease (CKD). By addressing SHPT, PTX can help manage the mineral and bone metabolism disruption associated with CKD-MBD, thereby reducing cardiovascular risks. The procedure aims to regulate PTH levels, which in turn can improve bone health and reduce the risk of fractures. It provides a way to manage the overactivity of the parathyroid glands that contributes to these complications.

3

What are the common biomarkers used to assess Kidney Disease-Mineral and Bone Disorder (CKD-MBD) and how do they help?

Researchers and clinicians use non-invasive biomarkers to assess Kidney Disease-Mineral and Bone Disorder (CKD-MBD). These biomarkers provide valuable insights into the complex interplay between kidney disease, bone health, and heart function, guiding treatment strategies and improving patient outcomes. The common biomarkers include: Intact parathyroid hormone (iPTH) regulates bone remodeling; Bone-specific alkaline phosphatase (BAP) indicates bone formation; Tartrate-resistant acid phosphatase 5b (TRACP-5b) indicates bone resorption; Fibroblast growth factor 23 (FGF23) is a hormone derived from bone.

4

How does Secondary Hyperparathyroidism (SHPT) affect heart health and overall mortality in patients with Chronic Kidney Disease (CKD)?

Secondary Hyperparathyroidism (SHPT) significantly impacts heart health and overall mortality in patients with Chronic Kidney Disease (CKD). In SHPT, the parathyroid glands become overactive, leading to excess parathyroid hormone (PTH) production. This exacerbates bone pain and fractures and increases cardiovascular disease (CVD) and mortality risks. The mineral and bone metabolism disruption associated with SHPT contributes to vascular calcification and further elevates cardiovascular risks. Managing SHPT through interventions like Parathyroidectomy (PTX) is critical in reducing these risks and improving patient outcomes.

5

Beyond Parathyroidectomy (PTX), what other steps can individuals with Chronic Kidney Disease (CKD) take to protect their heart health?

Besides considering Parathyroidectomy (PTX), individuals with Chronic Kidney Disease (CKD) can take several proactive steps to protect their heart health. It is crucial to work closely with your healthcare team to monitor bone markers and manage PTH levels. Monitoring Intact parathyroid hormone (iPTH), Bone-specific alkaline phosphatase (BAP), Tartrate-resistant acid phosphatase 5b (TRACP-5b), and Fibroblast growth factor 23 (FGF23) can offer insights into bone health and mineral metabolism. Furthermore, explore all available treatment options and adhere to prescribed medications. Maintaining a healthy lifestyle, including a balanced diet, regular exercise, and avoiding smoking, is also essential to mitigate cardiovascular risks. Regular check-ups and open communication with healthcare providers are vital for proactive management of CKD and its cardiovascular implications.

Newsletter Subscribe

Subscribe to get the latest articles and insights directly in your inbox.